Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14774755 | 1.00 | ALDH1A1 (0.69) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL24781213 | 1.00 | ALDH1A1 (0.69) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL28225879 | 0.93 | ALDH1A1 (0.69) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL14775862 | 0.92 | ALDH1A1 (0.67) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL14774904 | 0.92 | ALDH1A1 (0.67) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL14781360 | 0.92 | ALDH1A1 (0.67) | ALDH1A1KMT2AMEN1MAPTTHRB | |
| SCHEMBL14774891 | 0.89 | ALDH1A1 (0.75) | ALDH1A1KMT2AMEN1MAPTHPGD | |
| SCHEMBL14774675 | 0.89 | ALDH1A1 (0.75) | ALDH1A1KMT2AMEN1MAPTHPGD | |
| SCHEMBL19760402 | 0.86 | ALDH1A1 (0.60) | ALDH1A1KMT2AMEN1MAPTHPGD | |
| SCHEMBL14774931 | 0.86 | MEN1 (0.71) | ALDH1A1KMT2AMEN1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12262725-B2 | Improving taste profile of orange juice | SYMRISE AG (DE) | 2025-04-01 | — | — | US | disclosed |
| US-20180360086-A1 | FOODSTUFF (III) | SYMRISE AG (DE) | 2018-12-20 | — | — | US | disclosed |
| EP-3367818-A1 | FOODSTUFF (III) | Symrise AG (DE) | 2018-09-05 | — | — | EP | disclosed |
| WO-2017071784-A1 | FOODSTUFF (III) | SYMRISE AG (DE) | 2017-05-04 | — | — | WO | disclosed |
| WO-2017071784-A1 | FOODSTUFF (III) | SYMRISE AG (DE) | 2017-05-04 | — | — | WO | disclosed |
| US-9131716-B2 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2015-09-15 | — | — | US | disclosed |
| US-9131716-B2 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2015-09-15 | — | — | US | disclosed |
| US-9131716-B2 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2015-09-15 | — | — | US | disclosed |
| EP-2570035-B1 | Use of neoflavanoids for modifying taste | SYMRISE AG (DE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2570035-B1 | Use of neoflavanoids for modifying taste | SYMRISE AG (DE) | 2014-06-18 | — | — | EP | disclosed |
| US-20130078192-A1 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2013-03-28 | — | — | US | disclosed |
| US-20130078192-A1 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2013-03-28 | — | — | US | disclosed |
| US-20130078192-A1 | Use of neoflavonoids for flavor modification | SYMRISE AG (DE) | 2013-03-28 | — | — | US | disclosed |
| EP-2570035-A1 | Use of neoflavanoids for modifying taste | Symrise AG (DE) | 2013-03-20 | — | — | EP | disclosed |
| EP-2570035-A1 | Use of neoflavanoids for modifying taste | Symrise AG (DE) | 2013-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130078192-A1 | Use of neoflavonoids for flavor modification | TAS2R20, TAS2R60, TAS2R50 | ALDH1A1 401/4885KMT2A 2978/4885MEN1 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.